Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.75% |
| 2 | Healthcare | 9.01% |
| 3 | Technology | 7.75% |
| 4 | Financials | 7.01% |
| 5 | Consumer Discretionary | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Clear Channel Outdoor Holdings
CCO
$1.22B
| $1.76M | ﹤0.01% |
1,695,598
+206,513
| +14% | +$194K |
|
2577
PUT
Masco
MAS
$14.4B
| $1.76M | ﹤0.01% |
35,100
+24,400
| +228% | +$1.06M |
|
2578
Seres Therapeutics
MCRB
$49.7M
| $1.76M | ﹤0.01% |
+18,513
| New | +$1.62M |
|
2579
BioXcel Therapeutics
BTAI
$22.5M
| $1.76M | ﹤0.01% |
+2,073
| New | +$1.35M |
|
2580
AGCO
AGCO
$7.77B
| $1.75M | ﹤0.01% |
31,624
-47,113
| -60% | -$2.46M |
|
2581
PUT
Charles River Laboratories
CRL
$14.2B
| $1.74M | ﹤0.01% |
+10,000
| New | +$1.6M |
|
2582
PUT
HP
HPQ
$26.7B
| $1.74M | ﹤0.01% |
100,000
| – | – |
|
|
BFS
2583
Saul Centers
BFS
$827M
| $1.74M | ﹤0.01% |
53,899
+22,103
| +70% | +$705K |
|
2584
Matador Resources
MTDR
$7.02B
| $1.74M | ﹤0.01% |
204,383
-2,530,409
| -93% | -$17.7M |
|
|
AGRX
2585
DELISTED
Agile Therapeutics
AGRX
| $1.74M | ﹤0.01% |
312
-382
| -55% | -$1.98M |
|
|
LOVE
2586
LoveSac
LOVE
$235M
| $1.73M | ﹤0.01% |
65,789
-16,508
| -20% | -$251K |
|
2587
iShares MSCI USA Momentum Factor ETF
MTUM
$24.7B
| $1.72M | ﹤0.01% |
+13,164
| New | +$1.59M |
|
2588
Pegasystems
PEGA
$5.9B
| $1.72M | ﹤0.01% |
33,914
-409,532
| -92% | -$17.7M |
|
2589
Macy's
M
$5.92B
| $1.71M | ﹤0.01% |
249,196
+187,543
| +304% | +$1.15M |
|
2590
PUT
Quest Diagnostics
DGX
$27B
| $1.71M | ﹤0.01% |
+15,000
| New | +$1.59M |
|
|
MODN
2591
DELISTED
MODEL N, INC.
MODN
| $1.71M | ﹤0.01% |
49,173
-103,124
| -68% | -$3M |
|
2592
International Paper
IP
$21.1B
| $1.71M | ﹤0.01% |
51,213
-1,095,786
| -96% | -$34.9M |
|
|
OBSV
2593
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $1.71M | ﹤0.01% |
289,847
+268,165
| +1,237% | +$1.01M |
|
|
AMBR
2594
Amber International Holding Ltd
AMBR
$103M
| $1.7M | ﹤0.01% |
+31,945
| New | +$1.58M |
|
2595
Spyre Therapeutics
SYRE
$8.25B
| $1.7M | ﹤0.01% |
7,338
+6,781
| +1,217% | +$1.29M |
|
|
ENIA
2596
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $1.69M | ﹤0.01% |
+225,135
| New | +$1.75M |
|
2597
Mativ Holdings
MATV
$672M
| $1.69M | ﹤0.01% |
+50,507
| New | +$1.52M |
|
|
MMX
2598
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $1.69M | ﹤0.01% |
+379,992
| New | +$1.63M |
|
|
BGG
2599
DELISTED
Briggs & Stratton Corp.
BGG
| $1.69M | ﹤0.01% |
1,285,990
+1,254,373
| +3,967% | +$2.3M |
|
|
DCH
2600
Dauch Corp
DCH
$1.5B
| $1.68M | ﹤0.01% |
221,616
-1,138,738
| -84% | -$6.57M |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $10.9B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 48% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.